Quimatryx
Quimatryx is devoted to the Discovery and Development of novel drugs against epigenetic targets focused on the area of cancer. Quimatryx Ltd has designed a best in class HDAC6 selective inhibitor, QTX125, with the aim of reducing the side effects of the treatment and beating the therapeutic activity of other HDAC inhibitors. The most advanced compounds have already shown a higher in vivo efficacy and safety profiles than the reference compounds, to treat pancreatic cancer and other invasive tumours.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
9
11 to 50 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Quimatryx
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
Showing 1 of 6 verified contacts
Top roles at Quimatryx
5 distinct titles indexed · top 5 shown.
- 1chemical researcher r & d department
- 1director of manufacturing
- 1investigador químico departamento i d
- 1presidente
- 1production and analytical project manager
Sign up to unlock all 6 contacts at Quimatryx
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Quimatryx
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.